FDA Product Code MXD: Recorder, Event, Implantable Cardiac, (with Arrhythmia Detection)
Under FDA product code MXD, implantable cardiac event recorders with arrhythmia detection are cleared for long-term cardiac monitoring.
These subcutaneous devices continuously monitor the heart's electrical activity for up to three years, automatically storing ECG data when arrhythmias are detected or when the patient activates the device. They are used to diagnose unexplained syncope, palpitations, and cryptogenic stroke.
MXD devices are Class II medical devices, regulated under 21 CFR 870.1025 and reviewed by the FDA Cardiovascular panel.
Leading manufacturers include Medtronic, Inc., Biotronik, Inc. and Boston Scientific Corporation.
33
Total
33
Cleared
87d
Avg days
2014
Since
33 devices
Cleared
Feb 23, 2017
Reveal LINQ
Medtronic, Inc.
Cardiovascular
134d
Cleared
Feb 14, 2017
Reveal LINQ Insertable Cardiac Monitor
Medtronic, Inc.
Cardiovascular
67d
Cleared
May 26, 2016
Reveal LINQ
Medtronic, Inc.
Cardiovascular
63d
Cleared
Apr 22, 2016
Reveal LINQ
Medtronic, Inc.
Cardiovascular
42d
Cleared
Aug 06, 2015
Reveal LINQ
Medtronic, Inc.
Cardiovascular
149d
Cleared
Feb 14, 2014
REVEAL LINQ INSERTABLE CARDIAC MONITOR
Medtronic, Inc.
Cardiovascular
172d